Haemonetics (HAE) Reaches $64.12 52-Week High; BLINK CHARGING COMPANY (CCGI) SI Increased By 47.06%

January 14, 2018 - By Richard Conner

BLINK CHARGING COMPANY (OTCMKTS:CCGI) had an increase of 47.06% in short interest. CCGI’s SI was 2,500 shares in January as released by FINRA. Its up 47.06% from 1,700 shares previously. With 3,900 avg volume, 1 days are for BLINK CHARGING COMPANY (OTCMKTS:CCGI)’s short sellers to cover CCGI’s short positions. The stock increased 10.00% or $0.5 during the last trading session, reaching $5.5. About 6,932 shares traded or 208.09% up from the average. Blink Charging Co. (OTCMKTS:CCGI) has 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

The stock of Haemonetics Corporation (NYSE:HAE) hit a new 52-week high and has $69.89 target or 9.00% above today’s $64.12 share price. The 5 months bullish chart indicates low risk for the $3.39B company. The 1-year high was reported on Jan, 14 by Barchart.com. If the $69.89 price target is reached, the company will be worth $304.83M more. The stock decreased 0.99% or $0.64 during the last trading session, reaching $64.12. About 869,054 shares traded or 85.27% up from the average. Haemonetics Corporation (NYSE:HAE) has risen 45.56% since January 14, 2017 and is uptrending. It has outperformed by 28.86% the S&P500.

Since August 10, 2017, it had 0 buys, and 2 sales for $1.46 million activity. $448,434 worth of Haemonetics Corporation (NYSE:HAE) was sold by KROLL MARK W. 24,086 Haemonetics Corporation (NYSE:HAE) shares with value of $1.01 million were sold by MEELIA RICHARD J.

Analysts await Haemonetics Corporation (NYSE:HAE) to report earnings on February, 5. They expect $0.44 earnings per share, up 2.33% or $0.01 from last year’s $0.43 per share. HAE’s profit will be $23.24M for 36.43 P/E if the $0.44 EPS becomes a reality. After $0.48 actual earnings per share reported by Haemonetics Corporation for the previous quarter, Wall Street now forecasts -8.33% negative EPS growth.

Among 10 analysts covering Haemonetics Corporation (NYSE:HAE), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Haemonetics Corporation had 25 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Monday, May 16 by Goldman Sachs. The firm earned “Overweight” rating on Tuesday, January 2 by Morgan Stanley. The stock has “Outperform” rating by Barrington Research on Tuesday, November 8. The stock of Haemonetics Corporation (NYSE:HAE) earned “Hold” rating by Craig Hallum on Wednesday, November 8. Barrington Research upgraded it to “Outperform” rating and $43 target in Tuesday, July 28 report. Benchmark maintained the shares of HAE in report on Wednesday, May 11 with “Hold” rating. Jefferies maintained it with “Buy” rating and $40 target in Tuesday, August 2 report. Morgan Stanley maintained the stock with “Equal-Weight” rating in Thursday, November 9 report. The firm earned “Market Perform” rating on Tuesday, January 2 by Raymond James. The company was downgraded on Monday, November 23 by Raymond James.

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. The company has market cap of $3.39 billion. The firm operates through five divisions: North America Plasma; Americas Blood Center and Hospital; Europe, Middle East and Africa; Asia Pacific; and Japan. It has a 745.58 P/E ratio. It offers plasma collection and storage products, including PCS brand plasma collection equipment and disposables, plasma collection containers, and intravenous solutions, as well as information technology platforms for plasma clients to manage their donors, operations, and supply chain; Multicomponent Collection System brand apheresis equipment to collect specific blood components integrated from the donor; Automated Cell Processor brand solution to automate the washing and freezing of red cell components; and whole blood collection and processing products.

Investors sentiment decreased to 1.28 in Q3 2017. Its down 0.42, from 1.7 in 2017Q2. It turned negative, as 16 investors sold Haemonetics Corporation shares while 60 reduced holdings. 33 funds opened positions while 64 raised stakes. 52.55 million shares or 2.13% less from 53.69 million shares in 2017Q2 were reported. Martingale Asset L P owns 180,660 shares. Sentinel Asset Management holds 0.38% of its portfolio in Haemonetics Corporation (NYSE:HAE) for 350,226 shares. Chilton Inv Co Limited Liability Co has 172,744 shares for 0.3% of their portfolio. Amer Century Cos accumulated 49,704 shares. Great West Life Assurance Can accumulated 72,189 shares or 0.01% of the stock. 2.41 million were accumulated by Victory Mgmt Incorporated. Panagora Asset Mgmt, a Massachusetts-based fund reported 700,866 shares. Axa holds 21,200 shares. Invesco Ltd has 177,374 shares for 0% of their portfolio. Stifel Financial owns 12,791 shares. Fifth Third National Bank stated it has 529 shares. Systematic Fincl Management L P accumulated 35,360 shares. Ellington Mgmt Group Limited Liability Corporation, Connecticut-based fund reported 8,300 shares. Hutchin Hill Lp owns 27,000 shares. State Common Retirement Fund reported 0% in Haemonetics Corporation (NYSE:HAE).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com